Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 22, 2017
Pharmacy Choice - News - Generic Drugs - July 22, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 71     Next >>     Go To Page:

7/22/17 - Anti-Thrombin Activators Market: Upcoming Demands and Growth Analysis 2024
Transparency Market Research Report Added "Anti-thrombin Activators Market" to its database.Albany, NY 07/21/2017 Anti-thrombin activators are widely accepted due to their role in reducing thrombus formation. Anticoagulants, anti-platelet drugs, and thrombolytic drugs are some of the different types of anti-thrombin activators available, whic
7/22/17 - MSDs Lantus biosimilar given conditional FDA approval [Sudan Tribune]
However, there is a hitch to the good news for MSD, it is dependent upon a patent infringement lawsuit brought against them by Sanofi. The tentative approval of Lusduna Nexvue is an important milestone, bringing us closer to offering this medicine to patients, said Sam Engel, Associate Vice President of Merck Clinical Research. For Sanofi, the appr
7/22/17 - Sen. Grassley, Bipartisan Drug Affordability Cosponsors Urge FDA Commissioner to Reform Anticompetitive Drug Practices
Senate Judiciary Committee Chairman Chuck Grassley alongside Senators Patrick Leahy, Mike Lee, and Amy Klobuchar are asking Food and Drug Administration Commissioner Scott Gottlieb to address anticompetitive practices currently used by some brand-name pharmaceutical companies to delay the manufacture and introduction of generic drugs in the...
7/22/17 - Sen. Leahy, Bipartisan Drug Affordability CREATES Act Cosponsors Urge FDA Commissioner to Reform Anticompetitive Drug Practices
U.S. Senator Patrick Leahy, joined by Senators Chuck Grassley, Amy Klobuchar, and Mike Lee, are asking Food and Drug Administration Commissioner Scott Gottlieb to address anticompetitive practices currently used by some brand-name pharmaceutical companies to delay the manufacture and introduction of generic drugs in the market. The senators wrote:
7/21/17 - 1.5 Billion Pharmaceutical Deal for Quebec [Sudan Tribune]
The French province of Quebec in Canada is in line to save an estimated 1.5 billion dollars over the next five years- due to the fact that it has reached a deal with a number of pharmaceutical companies, which will now mean that the price for generic drugs will be less expensive. The Health Minister Gaetan Barrette only announced conformation of th
7/21/17 - ACETO Subsidiary, Rising Pharmaceuticals, Announces Product Launches
ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, recently launched:. Ramipril Capsules, 1.25 mg, 2.5 mg, 5 mg, and 10 mg,
7/21/17 - Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO [Palestine News Agency (WAFA)]
Mr. Ward has over thirty years of executive and legal experience in the healthcare, pharmaceutical and technology industries. Most recently, Mr. Ward served as Chief Compliance& Legal Officer and Corporate Secretary for Sagent Pharmaceuticals, a global specialty generic pharmaceutical company, and led its sale to Nichi-Iko Pharmaceutical Co., Ltd.
7/21/17 - Biologics and Biosimilars Market Analysis with Key Players, Applications, Trends and Forecasts to 2022
Biologics and BiosimilarsMarketanalysis is provided for global market including development trends by regions, competitive analysis ofbiologics and biosimilars market. Most products being developed as biosimilars are rec...
7/21/17 - Breckenridge Announces Final Approval for Omeprazole Delayed-Release Capsules
By a News Reporter-Staff News Editor at Drug Week Breckenridge Pharmaceutical, Inc. announced it has received U.S. Food and Drug Administration final approval of its abbreviated new drug application for Omeprazole delayed-release capsules, USP, in 10 mg, 20 mg, 40 mg strengths, which will be manufactured and supplied by its parent company, Labora
7/21/17 - ENDO INTERNATIONAL PLC FILES (8-K) Disclosing Costs Associated with Exit or Disposal Activities
The Registrant's Board of Directors approved the 2017 U.S. Generic Pharmaceuticals restructuring initiative on July 18, 2017. As a result of the 2017 U.S. Generic Pharmaceuticals restructuring initiative, the Registrant's workforce is expected to be reduced by approximately 875 positions, including approximately 35 open positions, and the Registran
7/21/17 - Momenta Pharmaceuticals Announces Jury Verdict in Enoxaparin Sodium Injection Patent Litigation Against Amphastar
Momenta Pharmaceuticals, Inc. today announced that the jury in the District Court for the District of Massachusetts in Boston has issued its verdict finding that the Company s U.S. Patent No. 7,575,886, covering methods for the manufacturing of generic LOVENOX , was infringed, but invalid and unenforceable.. Momenta Pharmaceuticals is a biot
7/21/17 - New Ampicillins Findings Reported from University of Antioquia (Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of...
New Ampicillins Findings Reported from University of Antioquia. According to news reporting out of Medellin, Colombia, by NewsRx editors, research stated, "Previous studies have demonstrated that pharmaceutical equivalence and pharmacokinetic equivalence of generic antibiotics are necessary but not sufficient conditions to guarantee therapeutic...
7/21/17 - Pfizer's Inflectra, Takeda's Entyvio, and Janssen's Simponi Projected to Gain Ground in the Increasingly Competitive Ulcerative Colitis Market
By a News Reporter-Staff News Editor at Drug Week Results from a recent study just released by Spherix Global Insights reveal that US gastroenterologists project significant growth of Takeda's Entyvio, Janssen's Simponi, and Pfizer/ Hospira's infliximab biosimilar, Inflectra over the next six months. While the positive bumps to Entyvio and Simpon
7/21/17 - Supply Of Drugs For Local Purchase In Ggsgh,branded Drugs,generic Drugs,dpco Drugs. [TendersInfo (India)]
Document Download/ Sale End Date: 17- Aug-2017 02:00 PM. Bid Submission End Date: 17- Aug-2017 02:00 PM. Bid Opening Date: 17- Aug-2017 02:30 PM Major organization: GURU GOVIND SINGH GOVT HOSPITAL Address: Office Of The Medical Superintendepnt Raghubir Nagar, New Delhi -110027 State: Delhi Attn: Medical Superintendepnt Country: India Email: msggsgh
7/21/17 - Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
Teligent, Inc., a New Jersey- based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application from the U.S. Food and Drug Administration of Erythromycin Topical Gel USP, 2%. "Erythromycin Topical Gel USP, 2% is Teligent's third FDA approval in 2017,'' commented Jason Gren
7/21/17 - Tired of the cost of prescription drugs? Share your story [The Buffalo News, N.Y.]
July 21 Juliana Keeping, of Oklahoma City, had to pay $1,000 out of pocket five times for a drug that prevented her 4- year-old son from catching a severe cold that could have had a catastrophic effect on his cystic fibrosis. Tanya Koller, 53, of Schenectady, has battled diabetes for decades and more recently was diagnosed with bipolar disord
7/20/17 - Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO
Aeterna Zentaris Inc., announced today that it has formed a special committee of independent directors to consider and evaluate various strategic and financing alternatives available to the Company to maximize shareholder value, including continuing to execute on its existing business plan and/or considering and recommending changes to the Company
7/20/17 - Ajanta Pharma set to give a major push to its US business in FY18 [Sudan Tribune]
Undeterred by pricing pressures and competition in the worlds largest market for generic drugs, Ajanta Pharma plans to rapidly scale up its US business. So far, Ajanta Pharma has filed 34 ANDAs, of which it has received 17 final approvals and two tentative approvals. We are awaiting approvals for 15 ANDAs and plan to file 12-15 ANDAs in FY 2018 wit
7/20/17 - GLENMARK, SPANISH COMPANY CYNDEA TEAM UP FOR SOFT-GELATIN CAPSULES
Glenmark Pharmaceuticals Limited has signed an agreement with Spain's Cyndea Pharma SL to exclusively use its technology for developing generic,. soft-gelatin capsule formulations for some pharmaceutical products. The agreement grants Glenmark Pharmaceuticals exclusive rights to the United States and Canada markets for these soft-gelatin...
7/20/17 - Global Biosimilars Market 2017 Key Growth Drivers, Challenges, Demand and Upcoming Trends
The global biosimilars market was USD 3.35 billion in 2016 which is expected to reach till USD 16.97 Billion by end of 2016 at a CAGR of 26% during 2017-2023. On regional basis, Europe has a leading biosimilars market. As it is the first region for the approval of biosimilars drug and well developed market has led to growth of biosimilars market in
7/20/17 - Grassley and Bipartisan Drug Affordability Cosponsors Urge FDA Commissioner to Reform Anticompetitive Drug Practices
WASHINGTON- Senate Judiciary Committee Chairman Chuck Grassley alongside Senators Patrick Leahy, Mike Lee, and Amy Klobuchar are asking Food and Drug Administration Commissioner Scott Gottlieb to address anticompetitive practices currently used by some brand-name pharmaceutical companies to delay the manufacture and introduction of generic drugs...
7/20/17 - Gwq Generic Tender (tacrolimus-aliud). [TendersInfo (India)]
Contract notice: Gwq generic tender. Conclusion of a generic agreement regarding products with the active ingredient tacrolimus of the manufacturer ALIUD PHARMA GmbH. Time-limit for receipt of tenders or requests to participate: Date 15/08/2017 Local time 1000 IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected
7/20/17 - Gwq Generic Tender (tacrolimus-astellas). [TendersInfo (India)]
Contract notice: Gwq generic tender. Conclusion of a generic agreement regarding products with the active ingredient Tacrolimus from the manufacturer Astellas Pharma GmbH. Time limit for receipt of tenders or requests to participate: Date: 15/08/2017 Local time: 10:00 Major organization: GWQ SERVICEPLUS AG Address: Tersteegenstr. 28 Dsseldorf 40476
7/20/17 - Gwq Generic Tender (tacrolimus-heumann). [TendersInfo (India)]
Contract notice: Gwq generic tender. Conclusion of a generic agreement agreement for products with the active ingredient Tacrolimus from the manufacturer Heumann Pharma GmbH& Co. Generika KG. Time limit for receipt of tenders or requests to participate: Date: 15/08/2017 Local time: 10:00 Major organization: GWQ SERVICEPLUS AG Address: Tersteegenstr
7/20/17 - Gwq Generic Tender (tacrolimus-stada). [TendersInfo (India)]
Contract notice: Gwq generic tender. Conclusion of a generic agreement agreement for products with the active substance tacrolimus of the manufacturer STADApharm GmbH. Time limit for receipt of tenders or requests to participate: Date: 15/08/2017 Local time: 10:00 Major organization: GWQ SERVICEPLUS AG Address: Tersteegenstr. 28 Dsseldorf 40474 Ger
Articles(s): 1 - 25 of 71     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415